|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/28/22 Viatris Inc. 10-K 12/31/21 144:22M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.39M
2: EX-21 Subsidiaries List HTML 85K
3: EX-22 Published Report re: Matters Submitted to a Vote HTML 39K
of Security Holders
4: EX-23 Consent of Expert or Counsel HTML 39K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
7: EX-32 Certification -- §906 - SOA'02 HTML 41K
13: R1 Cover HTML 106K
14: R2 Audit Information HTML 42K
15: R3 Audit Information HTML 40K
16: R4 Consolidated Balance Sheets HTML 146K
17: R5 Consolidated Balance Sheets (Parenthetical) HTML 46K
18: R6 Consolidated Statements of Operations HTML 131K
19: R7 Consolidated Statements of Comprehensive Earnings HTML 87K
20: R8 Consolidated Statements of Equity HTML 115K
21: R9 Consolidated Statements of Cash Flows HTML 148K
22: R10 Consolidated Statements of Equity (Parenthetical) HTML 40K
23: R11 Nature of Operations HTML 43K
24: R12 Summary of Significant Accounting Policies HTML 101K
25: R13 Acquisitions and Other Transactions HTML 88K
26: R14 Revenue Recognition and Accounts Receivable HTML 141K
27: R15 Balance Sheet Components HTML 110K
28: R16 Leases HTML 53K
29: R17 Equity Method Investments HTML 66K
30: R18 Financial Instruments and Risk Management HTML 266K
31: R19 Comprehensive Earnings HTML 149K
32: R20 Income Taxes HTML 175K
33: R21 Share-Based Incentive Plan HTML 75K
34: R22 Employee Benefit Plans HTML 228K
35: R23 Segment Information HTML 102K
36: R24 Restructuring HTML 94K
37: R25 Valuation and Qualifying Accounts HTML 61K
38: R26 Summary of Significant Accounting Policies HTML 153K
(Policies)
39: R27 Summary of Significant Accounting Policies HTML 60K
(Tables)
40: R28 Acquisitions and Other Transactions (Tables) HTML 79K
41: R29 Revenue Recognition and Accounts Receivable HTML 124K
(Tables)
42: R30 Balance Sheet Components (Tables) HTML 123K
43: R31 Leases (Tables) HTML 52K
44: R32 Equity Method Investments (Tables) HTML 64K
45: R33 Goodwill and Other Intangible Assets (Tables) HTML 148K
46: R34 Financial Instruments and Risk Management (Tables) HTML 218K
47: R35 Debt (Tables) HTML 68K
48: R36 Comprehensive Earnings (Tables) HTML 151K
49: R37 Income Taxes (Tables) HTML 158K
50: R38 Share-Based Incentive Plan (Tables) HTML 77K
51: R39 Employee Benefit Plans (Tables) HTML 229K
52: R40 Segment Information (Tables) HTML 99K
53: R41 Restructuring (Tables) HTML 88K
54: R42 Nature of Operations (Narrative) (Details) HTML 42K
55: R43 Summary of Significant Accounting Policies HTML 78K
(Narrative) (Details)
56: R44 Summary of Significant Accounting Policies (Basic HTML 74K
And Diluted Earnings Per Ordinary Share
Attributable To Mylan N.V.) (Details)
57: R45 Acquisitions and Other Transactions (Other HTML 145K
Transactions) (Narrative) (Details)
58: R46 Acquisitions and Other Transactions (Purchase HTML 111K
Price Allocations) (Details)
59: R47 Acquisitions and Other Transactions (Unaudited Pro HTML 54K
Forma Financial Results) (Details)
60: R48 Revenue Recognition and Accounts Receivable HTML 78K
Revenue Disaggregation (Details)
61: R49 Revenue Recognition and Accounts Receivable - HTML 76K
Disaggregation of Revenue by Key Products
(Details)
62: R50 Revenue Recognition and Accounts Receivable HTML 44K
(Narrative) (Details)
63: R51 Revenue Recognition and Accounts Receivable HTML 59K
Variable Consideration (Details)
64: R52 Revenue Recognition and Accounts Receivable HTML 65K
(Accounts Receivable, Net) (Details)
65: R53 Revenue Recognition and Accounts Receivable HTML 67K
Variable Consideration Rollforward (Details)
66: R54 Balance Sheet Components (Narrative) (Details) HTML 53K
67: R55 Balance Sheet Components Balance Sheet Components HTML 49K
(Cash and Cash Equivalents) (Details)
68: R56 Balance Sheet Components (Accounts receivable, HTML 51K
net) (Details)
69: R57 Balance Sheet Components (Inventories) (Details) HTML 53K
70: R58 Balance Sheet Components (Prepaids and other HTML 58K
current assets) (Details)
71: R59 Balance Sheet Components (Property, Plant and HTML 57K
Equipment) (Details)
72: R60 Balance Sheet Components (Other Assets) (Details) HTML 50K
73: R61 Balance Sheet Components (Trade Accounts Payable) HTML 46K
(Details)
74: R62 Balance Sheet Components (Other Current HTML 75K
Liabilities) (Details)
75: R63 Balance Sheet Components (Other noncurrent HTML 59K
liabilities) (Details)
76: R64 Leases (Narrative) (Details) HTML 61K
77: R65 Leases (Lease Information) (Details) HTML 49K
78: R66 Leases (Lease Maturities) (Details) HTML 58K
79: R67 Equity Method Investments (Narrative) (Details) HTML 48K
80: R68 Equity Method Investments (Balance Sheet) HTML 52K
(Details)
81: R69 Equity Method Investments (Net Assets) (Details) HTML 95K
82: R70 Equity Method Investments (Income Statement) HTML 75K
(Details)
83: R71 Goodwill and Other Intangible Assets (Narrative) HTML 133K
(Details)
84: R72 Goodwill and Other Intangible Assets (Changes in HTML 78K
Carrying Amount Of Goodwill) (Details)
85: R73 Goodwill and Other Intangible Assets (Components HTML 54K
of Intangible Assets) (Details)
86: R74 Goodwill and Other Intangible Assets (Product HTML 73K
Rights and License by Therapeutic Category)
(Details)
87: R75 Goodwill and Other Intangible Assets (Amortization HTML 49K
Expense) (Details)
88: R76 Goodwill and Other Intangible Assets Goodwill and HTML 50K
Other Intangible Assets (Future amortization
expense) (Details)
89: R77 Financial Instruments and Risk Management HTML 150K
(Narrative) (Details)
90: R78 Financial Instruments and Risk Management HTML 54K
(Derivatives Designated as Hedging Instruments
Fair Values of Derivative Instruments) (Details)
91: R79 Financial Instruments and Risk Management HTML 54K
(Derivatives Not Designated as Hedging Instruments
Fair Values of Derivative Instruments) (Details)
92: R80 Financial Instruments and Risk Management (Effect HTML 56K
of Derivative Instruments on the Consolidated
Statements of Operations Derivatives in Fair Value
Hedging Relationships) (Details)
93: R81 Financial Instruments and Risk Management (Effect HTML 46K
of Derivative Instruments on the Consolidated
Statements of Comprehensive Earnings Derivatives
in Cash Flow Hedging Relationships) (Details)
94: R82 Financial Instruments and Risk Management (Effect HTML 57K
of Derivative Instruments on the Condensed
Consolidated Statements of Comprehensive Earnings
Derivatives in Net Investment Hedging
Relationship) (Details)
95: R83 Financial Instruments and Risk Management (Effect HTML 58K
of Derivative Instruments on the Consolidated
Statements of Operations Derivatives in Cash Flow
Hedging Relationships) (Details)
96: R84 Financial Instruments and Risk Management (Effect HTML 53K
of Derivative Instruments on the Consolidated
Statements of Operations Derivatives Not
Designated as Hedging Instruments) (Details)
97: R85 Financial Instruments and Risk Management HTML 111K
(Financial Assets and Liabilities Carried at Fair
Value) (Details)
98: R86 Financial Instruments and Risk Management HTML 58K
(Rollforward of Contingent Consideration)
(Details)
99: R87 Financial Instruments and Risk Management HTML 52K
(Schedule of Available-for-sale Securities
Reconciliation) (Details)
100: R88 Financial Instruments and Risk Management HTML 50K
(Maturities of Available-for-sale Debt Securities
at Fair Value) (Details)
101: R89 Debt (Short-term borrowings) (Details) HTML 50K
102: R90 Debt Debt (Receivables Facility and Commercial HTML 62K
Paper Program) (Details)
103: R91 Debt (Summary of Long-term Debt) (Details) HTML 128K
104: R92 Debt (Revolving Facilities and Term Facilities) HTML 41K
(Details)
105: R93 Debt (Issuance of 2018 Senior Notes) (Details) HTML 48K
106: R94 Debt (Senior Notes) (Details) HTML 101K
107: R95 Debt (Fair Value) (Narrative) (Details) HTML 47K
108: R96 Debt (Upjohn Senior Notes) (Details) HTML 76K
109: R97 Debt (Minimum Repayments on Outstanding HTML 59K
Borrowings) (Details)
110: R98 Comprehensive Earnings (Accumulated Other HTML 89K
Comprehensive Loss) (Details)
111: R99 Comprehensive Earnings (Components of Other HTML 176K
Comprehensive Loss) (Details)
112: R100 Income Taxes (Narrative) (Details) HTML 101K
113: R101 Income Taxes (Schedule of Components of Income Tax HTML 87K
Provision) (Details)
114: R102 Income Taxes (Schedule of Deferred Tax Assets and HTML 81K
Liabilities) (Details)
115: R103 Income Taxes (Statutory Tax Rate to Effective Tax HTML 100K
Rate Reconciliation) (Details)
116: R104 Income Taxes (Schedule of Unrecognized Tax HTML 57K
Benefits) (Details)
117: R105 Share-Based Incentive Plan (Narrative) (Details) HTML 103K
118: R106 Share-Based Incentive Plan (Stock Awards) HTML 70K
(Details)
119: R107 Share-Based Incentive Plan (Nonvested Restricted HTML 61K
Stock, Restricted Stock Units and PSUs Activity)
(Details)
120: R108 Share-Based Incentive Plan (Valuation Assumptions) HTML 53K
(Details)
121: R109 Employee Benefit Plans (Narrative) (Details) HTML 63K
122: R110 Employee Benefit Plans (Accumulated Other HTML 52K
Comprehensive Income (Loss) Pretax Amounts Not Yet
Reclassified in Net Periodic Benefit Cost
(Details)
123: R111 Employee Benefit Plans (Change in Accumulated HTML 64K
Income (Loss) Relating to Defined Benefit Pension
and Other Postretirement Benefits) (Details)
124: R112 Employee Benefit Plans (Net Periodic Benefit HTML 73K
Costs) (Details)
125: R113 Employee Benefit Plans (Changes in Projected HTML 102K
Benefit Obligations, Plan Assets and Funded
Status) (Details)
126: R114 Employee Benefit Plans (Net Accrued Benefit Costs HTML 56K
Classification on Balance Sheet) (Details)
127: R115 Employee Benefit Plans (Plans with PBO in Excess HTML 48K
of Plan Assets) (Details)
128: R116 Employee Benefit Plans (Fair Values of Plan HTML 72K
Assets) (Details)
129: R117 Employee Benefit Plans (Weighted Average HTML 60K
Assumptions) (Details)
130: R118 Employee Benefit Plans (Estimated Future Benefit HTML 59K
Payments) (Details)
131: R119 Segment Information (Reconciliation of Segment HTML 80K
Information to Total Consolidated Information)
(Details)
132: R120 Segment Information (Third Party Net Sales by HTML 50K
Major Customers) (Details)
133: R121 Segment Information (Net Third Party Sales HTML 49K
Classified Based on Geographic Location of Entity)
(Details)
134: R122 Commitments (Details) HTML 49K
135: R123 Restructuring (Narrative) (Details) HTML 81K
136: R124 Restructuring (2020 Restructuring Plan) (Details) HTML 103K
137: R125 Collaboration and Licensing Agreements (Narrative) HTML 115K
(Details)
138: R126 Litigation (Narrative) (Details) HTML 126K
139: R127 Valuation and Qualifying Accounts (Details) HTML 54K
142: XML IDEA XML File -- Filing Summary XML 289K
140: XML XBRL Instance -- vtrs-20211231_htm XML 5.85M
141: EXCEL IDEA Workbook of Financial Reports XLSX 211K
9: EX-101.CAL XBRL Calculations -- vtrs-20211231_cal XML 304K
10: EX-101.DEF XBRL Definitions -- vtrs-20211231_def XML 2.32M
11: EX-101.LAB XBRL Labels -- vtrs-20211231_lab XML 3.76M
12: EX-101.PRE XBRL Presentations -- vtrs-20211231_pre XML 2.80M
8: EX-101.SCH XBRL Schema -- vtrs-20211231 XSD 392K
143: JSON XBRL Instance as JSON Data -- MetaLinks 816± 1.23M
144: ZIP XBRL Zipped Folder -- 0001792044-22-000010-xbrl Zip 930K
| Document |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/22 | 4, 8-K | ||
| For Period end: | 12/31/21 | 10-K/A, 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/09/22 Viatris Inc. 10-Q 3/31/22 104:11M 5/06/22 Viatris Inc. S-3 4:431K Donnelley … Solutions/FA 5/06/22 Viatris Inc. S-3ASR 5/06/22 8:1.1M Donnelley … Solutions/FA |